Objective. Chronic hepatitis C infection afflicts millions of people worldwide. Although antiviral treatments are increasingly effective, many hepatitis C virus (HCV) patients avoid treatment, do not complete or respond to treatment, or have contraindications. Self-management interventions are one option for promoting behavioral changes leading to liver wellness and improved quality of life. Our objective was to evaluate whether the effects of the HCV self-management program were sustained at the 12-month follow-up assessment. Methods. Veteran Affairs patients with hepatitis C (N = 134; mean age = 54.6 years, 95% male, 41% ethnic minority, 48% homeless in last 5 years) were randomized to either a 6-week self-management workshop or an information-only intervention. The weekly 2-hour self-management sessions were based on a cognitive–behavioral program with hepatitis C–specific modules. Outcomes including hepatitis C knowledge, depression, energy, and health-related quality of life were measured at baseline, 6 weeks, 6 months, and 12 months later. Data were analyzed using repeated measures ANOVA. Results. Compared with the information-only group, participants attending the self-management workshop improved more on HCV knowledge (p < .005), SF-36 energy/vitality (p = .016), and the Quality of Well-Being Scale (p = .036). Similar trends were found for SF-36 physical functioning and Center for Epidemiologic Studies Short Depression Scale. Conclusion. Better outcomes were sustained among self-management participants at the 12-month assessment despite the intervention only lasting 6 weeks. HCV health care providers should consider adding self-management interventions for patients with chronic HCV.
AdinolfiL. E.GambardellaM.AndreanaA.TripodiM. F.UtiliR.RuggieroG. (2001). Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology, 33, 1358–1364.
2.
AllenJ. P.LittenR. Z.FertigJ. B.BaborT. (1997). A review of research on the Alcohol Use Disorders Identification Test (AUDIT). Alcoholism: Clinical and Experimental Research, 21, 613–619.
3.
AllenJ. P.ReinertD. F.VolkR. J. (2001). The alcohol use disorders identification test: An aid to recognition of alcohol problems in primary care patients. Preventive Medicine, 33, 428–433.
4.
AlterM. J.Kruszon-MoranD.NainanO. V.McQuillanG. M.GaoF.MoyerL. A.MargolisH. S. (1999). The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. New England Journal of Medicine, 341, 556–562.
5.
AndresenE. M.FoutsB. S.RomeisJ. C.BrownsonC. A. (1999). Performance of health-related quality-of-life instruments in a spinal cord injured population. Archives of Physical Medicine and Rehabilitation, 80, 877–884.
6.
AndresenE. M.MalmgrenJ. A.CarterW. B.PatrickD. L. (1994). Screening for depression in well older adults: Evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). American Journal of Preventive Medicine, 10, 77–84.
7.
BaborT. F.delaFuenteJ. R.SaundersJ.GrantM. (1992). The Alcohol Use Disorders Identification Test: Guidelines for use in primary health care (WHO Publication No. 92.4). Geneva, Switzerland: World Health Organization.
8.
BanduraA. (1986). Social foundations of thought and action. A social cognitive theory. Englewood Cliffs, NJ: Prentice Hall.
9.
BanduraA. (2001). Social cognitive theory: An agentic perspective. Annual Review of Psychology, 52, 1–26.
10.
BarlowJ. H.EllardD. R.HainsworthJ. M.JonesF. R.FisherA. (2005). A review of self-management interventions for panic disorders, phobias and obsessive-compulsive disorders. Acta Psychiatrica Scandinavica, 111, 272–285.
11.
BarlowJ. H.TurnerA. P.WrightC. C. (1998). Long-term outcomes of an arthritis self-management programme. British Journal of Rheumatology, 37, 1315–1319.
12.
BodenheimerT.LorigK.HolmanH.GrumbachK. (2002). Patient self-management of chronic disease in primary care. Journal of the American Medical Association, 288, 2469–2475.
13.
Centers for Disease Control and Prevention. (1998). Recommendations for prevention and control of HCV infection and HCV-related chronic disease. Morbidity and Mortality Weekly Report, 47(RR-19), 1–10.
14.
ChanW. L.HuiE.ChanC.CheungD.WongS.WongR.WooJ. (2011). Evaluation of chronic disease self-management programme (CDSMP) for older adults in Hong Kong. Journal of Nutrition, Health & Aging, 15, 209–214.
15.
CohenJ. (1992). A power primer. Psychological Bulletin, 112, 155–159.
16.
CohenJ. L.SauterS. V.deVellisR. F.deVellisB. M. (1986). Evaluation of arthritis self-management courses led by laypersons and by professionals. Arthritis & Rheumatism, 29, 388–393.
17.
CollocaL.MillerF. G. (2011). Role of expectations in health. Current Opinion in Psychiatry, 24, 149–155.
18.
CookT. D.CampbellD. T. (1979). Quasi-experimentation: Design and analysis issues for field settings. Boston, MA: Houghton Mifflin.
19.
CronanT. A.HayM.GroesslE.BigattiS.GallagherR.TomitaM. (1998). The effects of social support and education on health care costs after three years. Arthritis Care & Research, 11, 326–334.
20.
DamushT. M.WeinbergerM.ClarkD. O.TierneyW. M.RaoJ. K.PerkinsS. M.VerelK. (2002). Acute low back pain self-management intervention for urban primary care patients: Rationale, design, and predictors of participation. Arthritis & Rheumatism, 47, 372–379.
21.
DamushT. M.WeinbergerM.PerkinsS. M.RaoJ. K.TierneyW. M.QiR.ClarkD. O. (2003). Randomized trial of a self-management program for primary care patients with acute low back pain: Short-term effects. Arthritis & Rheumatism, 49, 179–186.
22.
Diabetes Prevention Program Research Group. (2003). Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care, 26, 2518–2523.
23.
DominitzJ. A.BoykoE. J.KoepsellT. D.HeagertyP. J.MaynardC.SporlederJ. L.YoungK. A. (2005). Elevated prevalence of hepatitis C infection in users of United States Veterans Medical Centers. Hepatology, 41(1), 88–96.
24.
DongboF.DingY.McGowanP.FuH. (2006). Qualitative evaluation of chronic disease self management program (CDSMP) in Shanghai. Patient Education and Counseling, 61, 389–396.
25.
ElzenH.SlaetsJ. P.SnijdersT. A.SteverinkN. (2007). Evaluation of the chronic disease self-management program (CDSMP) among chronically ill older people in the Netherlands. Social Science & Medicine, 64, 1832–1841.
26.
FriedM. W.HadziyannisS. J. (2004). Treatment of chronic hepatitis C infection with peginterferons plus ribavirin. Seminars in Liver Disease, 24(Suppl. 2), 47–54.
27.
FriedM. W.ShiffmanM. L.ReddyK. R.SmithC.MarinosG.GoncalesF. L.YuJ. (2002). Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. New England Journal of Medicine, 347, 975–982.
28.
FuD.FuH.McGowanP.ShenY. E.ZhuL.YangH.WiZ. (2003). Implementation and quantitative evaluation of chronic disease self-management programme in Shanghai, China: Randomized controlled trial. Bulletin of the World Health Organization, 81, 174–182.
29.
GaniatsT. G.PalinkasL. A.KaplanR. M. (1992). Comparison of Quality of Well-Being scale and Functional Status Index in patients with atrial fibrillation. Medical Care, 30, 958–964.
30.
GianniniE.CeppaP.TestaR. (2001). Steatosis in chronic hepatitis C: Can weight reduction improve therapeutic efficacy?Journal of Hepatology, 35, 432–433.
31.
GiffordA. L.CunninghamW. E.HeslinK. C.AndersenR. M.NakazonoT.LieuD. K.BozzettS. A. (2002). Participation in research and access to experimental treatments by HIV-infected patients. New England Journal of Medicine, 346, 1373–1382.
32.
GiffordA. L.GroesslE. J. (2002). Chronic disease self-management and adherence to HIV medications. Journal of Acquired Immune Deficiency Syndrome, 31(Suppl. 3), S163–S166.
33.
GjeruldsenS.LogeJ. H.MyrvangB.OpjordsmoenS. (2006). Drug addiction in hepatitis C patients leads to a lower quality of life. Nordic Journal of Psychiatry, 60, 157–161.
34.
GlackenM.KernohanG.CoatesV. (2001). Diagnosed with hepatitis C: A descriptive exploratory study. International Journal of Nursing Studies, 38(1), 107–116.
35.
GroesslE. J.WeingartK. R.GiffordA. L.AschS. M.HoS. B. (2011). Development of the hepatitis C self-management program. Patient Education and Counseling, 83, 252–255.
36.
GroesslE. J.WeingartK. R.KaplanR. M.ClarkJ. A.GiffordA. L.HoS. B. (2008). Living with hepatitis C: Qualitative interviews with hepatitis C-infected veterans. Journal of General Internal Medicine, 23, 1959–1965.
37.
GroesslE. J.WeingartK. R.KaplanR. M.HoS. B. (2007). Health-related quality of life in HCV infected patients. Current Hepatitis Reports, 6, 169–175.
38.
GroesslE. J.WeingartK. R.StepnowskyC. J.GiffordA. L.AschS. M.HoS. B. (2010). The hepatitis C self-management programme: A randomized controlled trial. Journal of Viral Hepatitis, 18, 358–368.
39.
GroomH.DieperinkE.NelsonD. B.GarrardJ.JohnsonJ. R.EwingS. L.HoS. B. (2008). Outcomes of a hepatitis C screening program at a large urban VA medical center. Journal of Clinical Gastroenterology, 42, 97–106.
HeintgesT.WandsJ. R. (1997). Hepatitis C virus: Epidemiology and transmission. Hepatology, 26, 521–526.
42.
HickmanI. J.CloustonA. D.MacdonaldG. A.PurdieD. M.PrinsJ. B.AshS.PowellE. E. (2002). Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. Gut, 51, 89–94.
43.
HickmanI. J.JonssonJ. R.PrinsJ. B.AshS.PurdieD. M.CloustonA. D.PowellE. E. (2004). Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut, 53, 413–419.
44.
HoS. B.GroesslE.DollarhideA.RobinsonS.KravetzD.DieperinkE. (2008). Management of chronic hepatitis C in veterans: The potential of integrated care models. American Journal of Gastroenterology, 103, 1810–1823.
45.
HongB. A.NorthC. S.PollioD. E.AbbacchiA.DeboldC.AdewuyiS. A.Lisker-MelmanM. (2011). The use of psychoeducation for a patient with hepatitis C and psychiatric illness in preparation for antiviral therapy: A case report and discussion. Journal of Clinical Psychology in Medical Settings, 18, 99–107.
46.
JacobsonI. M.McHutchisonJ. G.DusheikoG.Di BisceglieA. M.ReddyK. R.BzowejN. H.ZeuzemS. (2011). Telaprevir for previously untreated chronic hepatitis C virus infection. New England Journal of Medicine, 364, 2405–2416.
47.
JensenD. M. (2011). A new era of hepatitis C therapy begins. New England Journal of Medicine, 364, 1272–1274.
48.
KanwalF.GralnekI. M.HaysR. D.DulaiG. S.SpiegelB. M.BozzetteS.AschS. (2005). Impact of chronic viral hepatitis on health-related quality of life in HIV: Results from a nationally representative sample. American Journal of Gastroenterology, 100, 1984–1994.
49.
KaplanR. M. (2005). The minimally clinically important difference in generic utility-based measures. Journal of Chronic Obstructive Pulmonary Disease, 2, 91–97.
50.
KaplanR. M.AndersonJ. P. (1988). The quality of well-being scale: Rationale for a single quality of life index. Paper presented at the Centre for Medicines Research Workshop, CIBA Foundation, Lancaster, England.
51.
KaplanR. M.AndersonJ. P.PattersonT. L.McCutchanJ. A.WeinrichJ. D.HeatonR. K.GrantI. (1995). Validity of the Quality of Well-Being Scale for persons with human immunodeficiency virus infection. HNRC Group. HIV Neurobehavioral Research Center. Psychosomatic Medicine, 57, 138–147.
52.
KaplanR. M.RiesA. L.ReillyJ.MohsenifarZ. (2004). Measurement of health-related quality of life in the national emphysema treatment trial. Chest, 126, 781–789.
53.
KnowlerW. C.Barrett-ConnorE.FowlerS. E.HammanR. F.LachinJ. M.WalkerE. A.NathanD. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346, 393–403.
54.
KosinskiM.KellerS. D.HatoumH. T.KongS. X.WareJ. E. (1999). The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: Tests of data quality, scaling assumptions and score reliability. Medical Care, 37(Suppl. 5), MS10–MS22.
55.
LarreyD.SalseA.RibardD.BoutetO.Hyrailles-BlancV.NiangB.DauresJ. P. (2011). Education by a nurse increases response of patients with chronic hepatitis C to therapy with peginterferon-alpha2a and ribavirin. Clinical Gastroenterology and Hepatology, 9, 781–785.
56.
LorigK. (1996). Outcome measures for health education and other health care interventions. Thousand Oaks, CA: Sage.
57.
LorigK.FeigenbaumP.ReganC.UngE.ChastainR. L.HolmanH. R. (1986). A comparison of lay-taught and professional-taught arthritis self-management courses. Journal of Rheumatology, 13, 763–767.
58.
LorigK.GonzalezV. M.LaurentD. (1999). The chronic disease self-management workshop leaders manual. Palo Alto, CA: Stanford Patient Education Research Center.
59.
LorigK.HomanH.SobelD.LaurentD. (2000). Living a healthy life with chronic conditions. Palo Alto, CA: Bull.
60.
LorigK.LaurinJ.GinesG. E. (1984). Arthritis self-management. A five-year history of a patient education program. Nursing Clinics of North America, 19, 637–645.
61.
LorigK. R.HolmanH. (2003). Self-management education: history, definition, outcomes, and mechanisms. Annals of Behavioral Medicine, 26(1), 1–7.
62.
LorigK. R.MazonsonP. D.HolmanH. R. (1993). Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costs. Arthritis & Rheumatism, 36, 439–446.
63.
LorigK. R.RitterP.StewartA. L.SobelD. S.BrownB. W.BanduraA.HolmanH. R. (2001). Chronic disease self-management program: 2-Year health status and health care utilization outcomes. Medical Care, 39, 1217–1223.
64.
LorigK. R.RitterP. L.JacquezA. (2005). Outcomes of border health Spanish/English chronic disease self-management programs. Diabetes Educator, 31, 401–409.
65.
LorigK. R.SobelD. S.RitterP. L.LaurentD.HobbsM. (2001). Effect of a self-management program on patients with chronic disease. Effective Clinical Practice, 4, 256–262.
66.
McGowanP. (2004). The diabetes self-management program in British Columbia. Victoria, British Columbia, Canada: University of Victoria, Centre on Aging.
67.
MericanI.SherlockS.McIntyreN.DusheikoG. M. (1993). Clinical, biochemical and histological features in 102 patients with chronic hepatitis C virus infection. Quarterly Journal of Medicine, 86, 119–125.
68.
MontoA.PatelK.BostromA.PiankoS.PockrosP.McHutchisonJ. G.WrghtT. L. (2004). Risks of a range of alcohol intake on hepatitis C-related fibrosis. Hepatology, 39, 826–834.
69.
OsborneR.WilsonT.McCollG. (2002). Does self-management lead to meaningful and sustainable change? Two-year follow-up of 452 Australians. Paper presented at the Commonwealth Department of Health and Ageing Sharing Health Care Initiative Early Wins Workshop, Hobart, Australia.
70.
PatrickD. L.RamseyS. D.SpencerA. C.KinneS.BelzaB.TopolskiT. D. (2001). Economic evaluation of aquatic exercise for persons with osteoarthritis. Medical Care, 39, 413–424.
71.
PessioneF.DegosF.MarcelliinP.DuchatelleV.NiapoumC.Martinot-PeignouxM.RueffB. (1998). Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology, 27, 1717–1722.
72.
PoordadF.McConeJ.BaconB. R.BrunoS.MannsM. P.SulkowskiM. S.BronowickiJ.-P. (2011). Boceprevir for untreated chronic HCV genotype 1 infection. New England Journal of Medicine, 364, 1195–1206.
73.
PyneJ. M.PattersonT. L.KaplanR. M.GillinJ. C.KochW. L.GrantI. (1997). Assessment of the quality of life of patients with major depression. Psychiatric Services, 48, 224–230.
74.
ReinertD. F.AllenJ. P. (2002). The Alcohol Use Disorders Identification Test (AUDIT): A review of recent research. Alcoholism: Clinical & Experimental Research, 26, 272–279.
75.
RiesA. L.KaplanR. M.MyersR.PrewittL. M. (2003). Maintenance after pulmonary rehabilitation in chronic lung disease: A randomized trial. American Journal of Respiratory and Critical Care Medicine, 167, 880–888.
76.
RowanP. J.Al-JurdiR.Tavakoli-TabasiS.KunikM. E.SatromS. L.El-SeragH. B. (2005). Physical and psychosocial contributors to quality of life in veterans with hepatitis C not on antiviral therapy. Journal of Clinical Gastroenterology, 39, 731–736.
77.
RowanP. J.TabasiS.Abdul-LatifM.KunikM. E.El-SeragH. B. (2004). Psychosocial factors are the most common contraindications for antiviral therapy at initial evaluation in veterans with chronic hepatitis C. Journal of Clinical Gastroenterology, 38, 530–534.
78.
SloanK. L.Straits-TrosterK. A.DominitzJ. A.KivlahanD. R. (2004). Hepatitis C tested prevalence and comorbidities among veterans in the US Northwest. Journal of Clinical Gastroenterology, 38, 279–284.
79.
StewartA. L.HaysR. D.WareJ. E. (1988). The MOS short-form general health survey. Reliability and validity in a patient population. Medical Care, 26, 724–735.
80.
TobinD.ReynoldsR.HolroydK.CreerT. (1986). Self-management and social learning theory. In HolroydK. A.CreerT. L. (Eds.), Self-management of chronic disease: Handbook of clinical interventions and research (pp. 29–52). Orlando, FL: Academic Press.
81.
U.S. Department of Veteran Affairs. (2005). Hepatitis C Resource Center Program and National Hepatitis C Program Office. Retrieved from http://www.hepatitis.va.gov/hcrc-index.asp
82.
U.S. Department of Veteran Affairs. (2007a). VA National Hepatitis C Program. Retrieved from http://www.hepatitis.va.gov/
van den HoutW. B.de JongZ.MunnekeM.HazesJ. M.BreedveldF. C.Vliet VlielandT. P. (2005). Cost-utility and cost-effectiveness analyses of a long-term, high-intensity exercise program compared with conventional physical therapy in patients with rheumatoid arthritis. Arthritis & Rheumatism, 53, 39–47.
85.
WalkerC.WeeksA.McAvoyB.DemetriouE. (2005). Exploring the role of self-management programmes in caring for people from culturally and linguistically diverse backgrounds in Melbourne, Australia. Health Expectations, 8, 315–323.
86.
WareJ. E.KosinskiM.Turner-BowkerD. M.GandekB. (2002). How to score Version 2 of the SF-12 Health Survey (with a supplement documenting Version 1). Lincoln, RI: QualityMetric.
87.
WareJ. E.KosinskiM. A.KellerS. D. (1994). SF-36 Physical and Mental Health Summary Scales: A user’s manual (5th ed.). Boston, MA: Health Assessment Lab, New England Medical Center.
88.
WrightS. P.WalshH.IngleyK. M.MuncasterS. A.GambleG. D.PearlA.DoughtyR. N. (2003). Uptake of self-management strategies in a heart failure management programme. European Journal of Heart Failure, 5, 371–380.
